These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays. Tsantes AE; Ikonomidis I; Papadakis I; Bonovas S; Gialeraki A; Kottaridi C; Kyriakou E; Kokori S; Douramani P; Kopterides P; Karakitsos P; Lekakis J; Kapsimali V Thromb Res; 2013 Aug; 132(2):e105-11. PubMed ID: 23830212 [TBL] [Abstract][Full Text] [Related]
11. Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study. Price MJ; Murray SS; Angiolillo DJ; Lillie E; Smith EN; Tisch RL; Schork NJ; Teirstein PS; Topol EJ; J Am Coll Cardiol; 2012 May; 59(22):1928-37. PubMed ID: 22624833 [TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Utility of the Point-of-Care CYP2C19 Genotyping Assay in Patients with Acute Coronary Syndrome Dosing Clopidogrel: Comparison with Platelet Function Test and SNP Genotyping. Choi JL; Kim BR; Woo KS; Kim KH; Kim JM; Kim MH; Han JY Ann Clin Lab Sci; 2016 Sep; 46(5):489-94. PubMed ID: 27650615 [TBL] [Abstract][Full Text] [Related]
13. Effect of genetic and coexisting polymorphisms on platelet response to clopidogrel in Chinese Han patients with acute coronary syndrome. Liu X; Luo Y; Lai Y; Yao Y; Li J; Wang Y; Zheng SL; Xu J; Liu X J Genet; 2016 Jun; 95(2):231-7. PubMed ID: 27350664 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome. Cuisset T; Quilici J; Cohen W; Fourcade L; Saut N; Pankert M; Gaborit B; Carrieri P; Morange PE; Bonnet JL; Alessi MC Am J Cardiol; 2011 Sep; 108(6):760-5. PubMed ID: 21803320 [TBL] [Abstract][Full Text] [Related]
15. Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting. Stimpfle F; Karathanos A; Droppa M; Metzger J; Rath D; Müller K; Tavlaki E; Schäffeler E; Winter S; Schwab M; Gawaz M; Geisler T Thromb Res; 2014 Jul; 134(1):105-10. PubMed ID: 24856643 [TBL] [Abstract][Full Text] [Related]
16. Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial. Diodati JG; Saucedo JF; Cardillo TE; Jakubowski JA; Henneges C; Effron MB; Lipkin FR; Walker JR; Duvvuru S; Sundseth SS; Fisher HN; Angiolillo DJ Thromb Haemost; 2014 Aug; 112(2):311-22. PubMed ID: 24718367 [TBL] [Abstract][Full Text] [Related]
17. CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome. Liu J; Nie XY; Zhang Y; Lu Y; Shi LW; Wang WM Chin Med J (Engl); 2015 Aug; 128(16):2183-8. PubMed ID: 26265611 [TBL] [Abstract][Full Text] [Related]
18. High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. Marcucci R; Giusti B; Paniccia R; Gori AM; Saracini C; Valente S; Giglioli C; Parodi G; Antoniucci D; Gensini GF; Abbate R Platelets; 2012; 23(8):586-93. PubMed ID: 22390861 [TBL] [Abstract][Full Text] [Related]
19. Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS. Peng L; Liu J; Qin L; Liu J; Xi S; Lu C; Yin T Thromb Res; 2017 Sep; 157():97-102. PubMed ID: 28734158 [TBL] [Abstract][Full Text] [Related]
20. A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients. Hassani Idrissi H; Hmimech W; Khorb NE; Akoudad H; Habbal R; Nadifi S BMC Res Notes; 2018 Jan; 11(1):46. PubMed ID: 29347970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]